These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 15504761)
1. Staphylococcal enterotoxins condition cells of the innate immune system for Toll-like receptor 4 stimulation. Rossi RJ; Muralimohan G; Maxwell JR; Vella AT Int Immunol; 2004 Dec; 16(12):1751-60. PubMed ID: 15504761 [TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor 4 mediates the antitumor host response induced by a 55-kilodalton protein isolated from Aeginetia indica L., a parasitic plant. Okamoto M; Oh-E G; Oshikawa T; Furuichi S; Tano T; Ahmed SU; Akashi S; Miyake K; Takeuchi O; Akira S; Himeno K; Sato M; Ohkubo S Clin Diagn Lab Immunol; 2004 May; 11(3):483-95. PubMed ID: 15138173 [TBL] [Abstract][Full Text] [Related]
3. CD40-mediated up-regulation of Toll-like receptor 4-MD2 complex on the surface of murine dendritic cells. Frleta D; Noelle RJ; Wade WF J Leukoc Biol; 2003 Dec; 74(6):1064-73. PubMed ID: 12960264 [TBL] [Abstract][Full Text] [Related]
4. Lipopolysaccharides from distinct pathogens induce different classes of immune responses in vivo. Pulendran B; Kumar P; Cutler CW; Mohamadzadeh M; Van Dyke T; Banchereau J J Immunol; 2001 Nov; 167(9):5067-76. PubMed ID: 11673516 [TBL] [Abstract][Full Text] [Related]
5. Injury primes the innate immune system for enhanced Toll-like receptor reactivity. Paterson HM; Murphy TJ; Purcell EJ; Shelley O; Kriynovich SJ; Lien E; Mannick JA; Lederer JA J Immunol; 2003 Aug; 171(3):1473-83. PubMed ID: 12874240 [TBL] [Abstract][Full Text] [Related]
6. T cell clonal conditioning: a phase occurring early after antigen presentation but before clonal expansion is impacted by Toll-like receptor stimulation. Maxwell JR; Rossi RJ; McSorley SJ; Vella AT J Immunol; 2004 Jan; 172(1):248-59. PubMed ID: 14688332 [TBL] [Abstract][Full Text] [Related]
7. Interaction of lipoteichoic acid and CpG-DNA during activation of innate immune cells. Dalpke AH; Frey M; Morath S; Hartung T; Heeg K Immunobiology; 2002 Oct; 206(4):392-407. PubMed ID: 12437070 [TBL] [Abstract][Full Text] [Related]
8. Synergistic and antagonistic interactions between LPS and superantigens. Dalpke AH; Heeg K J Endotoxin Res; 2003; 9(1):51-4. PubMed ID: 12691619 [TBL] [Abstract][Full Text] [Related]
9. Differential cytokine response in host defence mechanisms triggered by gram-negative and gram-positive bacteria, and the roles of gabexate mesilate, a synthetic protease inhibitor. Iwadou H; Morimoto Y; Iwagaki H; Sinoura S; Chouda Y; Kodama M; Yoshioka T; Saito S; Yagi T; Tanaka N J Int Med Res; 2002; 30(2):99-108. PubMed ID: 12025532 [TBL] [Abstract][Full Text] [Related]
10. The immune response modifier and Toll-like receptor 7 agonist S-27609 selectively induces IL-12 and TNF-alpha production in CD11c+CD11b+CD8- dendritic cells. Doxsee CL; Riter TR; Reiter MJ; Gibson SJ; Vasilakos JP; Kedl RM J Immunol; 2003 Aug; 171(3):1156-63. PubMed ID: 12874201 [TBL] [Abstract][Full Text] [Related]
11. Differential expression and function of Toll-like receptors in Langerhans cells: comparison with splenic dendritic cells. Mitsui H; Watanabe T; Saeki H; Mori K; Fujita H; Tada Y; Asahina A; Nakamura K; Tamaki K J Invest Dermatol; 2004 Jan; 122(1):95-102. PubMed ID: 14962096 [TBL] [Abstract][Full Text] [Related]
12. Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity. Supajatura V; Ushio H; Nakao A; Akira S; Okumura K; Ra C; Ogawa H J Clin Invest; 2002 May; 109(10):1351-9. PubMed ID: 12021251 [TBL] [Abstract][Full Text] [Related]
13. Analysis of the in vivo dendritic cell response to the bacterial superantigen staphylococcal enterotoxin B in the mouse spleen. Yoon S; Bae KL; Shin JY; Yoo HJ; Lee HW; Baek SY; Kim BS; Kim JB; Lee HD Histol Histopathol; 2001 Oct; 16(4):1149-59. PubMed ID: 11642735 [TBL] [Abstract][Full Text] [Related]
14. Toll-like receptor-mediated activation of B cells and macrophages by polysaccharide isolated from cell culture of Acanthopanax senticosus. Han SB; Yoon YD; Ahn HJ; Lee HS; Lee CW; Yoon WK; Park SK; Kim HM Int Immunopharmacol; 2003 Sep; 3(9):1301-12. PubMed ID: 12890428 [TBL] [Abstract][Full Text] [Related]
15. Expression of toll-like receptor 4 on dendritic cells is significant for anticancer effect of dendritic cell-based immunotherapy in combination with an active component of OK-432, a streptococcal preparation. Okamoto M; Furuichi S; Nishioka Y; Oshikawa T; Tano T; Ahmed SU; Takeda K; Akira S; Ryoma Y; Moriya Y; Saito M; Sone S; Sato M Cancer Res; 2004 Aug; 64(15):5461-70. PubMed ID: 15289356 [TBL] [Abstract][Full Text] [Related]
16. Induction of human dendritic cell maturation using transfection with RNA encoding a dominant positive toll-like receptor 4. Cisco RM; Abdel-Wahab Z; Dannull J; Nair S; Tyler DS; Gilboa E; Vieweg J; Daaka Y; Pruitt SK J Immunol; 2004 Jun; 172(11):7162-8. PubMed ID: 15153540 [TBL] [Abstract][Full Text] [Related]
17. Cutting edge: impaired Toll-like receptor expression and function in aging. Renshaw M; Rockwell J; Engleman C; Gewirtz A; Katz J; Sambhara S J Immunol; 2002 Nov; 169(9):4697-701. PubMed ID: 12391175 [TBL] [Abstract][Full Text] [Related]
18. Regulation of Toll-like receptor (TLR)2 and TLR4 on CD14dimCD16+ monocytes in response to sepsis-related antigens. Skinner NA; MacIsaac CM; Hamilton JA; Visvanathan K Clin Exp Immunol; 2005 Aug; 141(2):270-8. PubMed ID: 15996191 [TBL] [Abstract][Full Text] [Related]